Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 430 Issue 7002, 19 August 2004

Editorial

  • With the death of Francis Crick, biology is mourning one of its deepest thinkers. A work of futurology, published in 1970, reveals the extent of his prescience — and suggests challenges for today's theorists.

    Editorial

    Advertisement

  • Americans should worry less about their neighbour and more about the prestige of regulators who protect public health.

    Editorial
Top of page ⤴

News

Top of page ⤴

News in Brief

Top of page ⤴

News Feature

  • CERN, the centre for particle physics in Europe, has been smashing its way through the subatomic world for the past 50 years. Alison Abbott finds out what's in store for the future.

    • Alison Abbott
    News Feature
  • Archaeologists have failed to learn the secrets of Mexico's largest ancient monument. Particle physicists might save the day, says Michael Hopkin.

    • Michael Hopkin
    News Feature
Top of page ⤴

Correspondence

Top of page ⤴

Commentary

  • How to create a research council that is a Champions League for science.

    • Robert M. May
    Commentary
Top of page ⤴

Books & Arts

Top of page ⤴

Turning Points

Top of page ⤴

News & Views

  • By taking advantage of the cell's carbohydrate metabolism, reactive sugar analogues can be used to tag specific cells, potentially singling them out for imaging studies or drug delivery.

    • David A. Tirrell
    News & Views
  • A remarkable set of antimalarial drug candidates has been developed by an international collaboration of scientists, using the age-old Chinese herbal medicine artemisinin as a template.

    • Paul M. O'Neill
    News & Views
  • In high-temperature superconductors, quantized vortex filaments can be twisted up into a DNA-like double helix. An experiment is proposed to test how easily these vortex lines cut through each other.

    • David R. Nelson
    News & Views
  • During cell division everything must happen at the right time, or errors occur. A common cellular control device, protein phosphorylation, is now shown to time the assembly of a key part of the division machinery.

    • Bruce Bowerman
    News & Views
  • During the last glacial period, climatic variation in the Northern and Southern Hemispheres was evidently linked. Modelling work points to freshwater discharge into the North Atlantic as a driving factor.

    • Trond M. Dokken
    • Kerim H. Nisancioglu
    News & Views
  • An atomic picture of how anthrax toxin binds to its host's cells reveals that the toxin commandeers a host receptor protein and tricks it into helping the toxin enter the cell.

    • James G. Bann
    • Scott J. Hultgren
    News & Views
  • Alexander Rich and Charles F. Stevens, respectively an early collaborator of Crick's and a long-standing colleague at the Salk Institute, describe the life and work of one of the great thinkers of twentieth-century biology.

    • Alexander Rich
    • Charles F. Stevens
    News & Views
Top of page ⤴

Research Highlights

Top of page ⤴

Brief Communication

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Erratum

Top of page ⤴

Corrigendum

Top of page ⤴

Malaria

Top of page ⤴

Outlook

  • “It is high time we addressed the widening inequities that characterize our planet today. We need to focus our energies towards achieving basic healthcare for all.” Pascoal Mocumbi, former prime minister of Mozambique

    • Pascoal Mocumbi
    Outlook
  • Campaigns against malaria are multiplying, but so are malaria deaths. Brian Greenwood asks what can be done to turn the tide.

    • Brian Greenwood
    Outlook
  • In Africa, where malaria hits hardest, scientists are crying out for countries to take matters into their own hands, says Declan Butler.

    • Declan Butler
    Outlook
  • To win the fight against malaria we will need to scale up existing programmes and develop new weapons, say Richard Klausner and Pedro Alonso.

    • Richard Klausner
    • Pedro Alonso
    Outlook
  • International agencies have failed to meet their own malaria performance targets and should be held to account, says Amir Attaran.

    • Amir Attaran
    Outlook
  • We need to know how bad the malaria situation is before we can make it better, says Robert Snow.

    • Robert W. Snow
    Outlook
  • The malaria vector is back in scientists' sights, says Janet Hemingway, with insecticides and transgenic insects offering fresh hope.

    • Janet Hemingway
    Outlook
  • Documentary makers can get as close to the war zones of disease as doctors and researchers — perhaps even closer. Julie Clayton and Declan Butler talk to Kevin Hull about his experiences.

    • Julie Clayton
    • Declan Butler
    Outlook
  • The world must increase collaboration to meet the pressing need for a malaria vaccine, argue Carter Diggs, Sarah Ewart and Melinda Moree.

    • Melinda Moree
    • Sarah Ewart
    • Carter Diggs
    Outlook
  • Creating a malaria vaccine will be tough. But Africa needs one now more than ever, says Stephen Hoffman.

    • Stephen Hoffman
    Outlook
  • We have the science to make new antimalarials, say Robert Ridley and Yeya Toure, but we need better mechanisms and resources to develop drugs and deliver them.

    • Robert Ridley
    • Yeya Toure
    Outlook
  • The malaria and mosquito genomes will allow us to find new drug and vaccine targets, says Daniel Carucci.

    • Daniel Carucci
    Outlook
Top of page ⤴

Prospects

Top of page ⤴

Careers and Recruitment

  • Chemical biology, using chemical tools to solve biological problems, is awakening interest among students and creating a new breed of researcher, says Tim Chapman.

    • Tim Chapman
    Careers and Recruitment
Top of page ⤴

Nature Outlook

  • Malaria: The long road to a healthy Africa. The Naturezeroes in on the major issues in the war on malaria, with a particular focus on Africa. It analyses the current state of affairs, the major scientific and other obstacles in treatment and control, and the promising areas where substantial progress might be made.

    Nature Outlook
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links